Header cover image

Danish Biotech Stocks

Results

7

1 new
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

7 companies

Novo Nordisk

Market Cap: DKK 2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

NOVO B

DKK 456.85

7D

-4.9%

1Y

-46.9%

Genmab

Market Cap: DKK 81.7b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,285.00

7D

-8.1%

1Y

-38.3%

ALK-Abelló

Market Cap: DKK 31.5b

Operates as an allergy solutions company in Europe, North America, and internationally.

ALK B

DKK 142.40

7D

1.9%

1Y

16.6%

H. Lundbeck

Market Cap: DKK 30.8b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 32.06

7D

-11.7%

1Y

-6.1%

Bavarian Nordic

Market Cap: DKK 11.8b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 151.05

7D

-4.2%

1Y

-3.6%

Gubra

Market Cap: DKK 6.8b

A biotech company, provides pre-clinical contract research (CRO) services, and proprietary early target and drug discovery programs in Denmark and internationally..

New

GUBRA

DKK 416.00

7D

-5.9%

1Y

39.1%

Strategic Partners

Market Cap: DKK 37.5m

Does not have significant operations.

STRAP

DKK 900.10

7D

12.5%

1Y

-19.5%

Page 1 of 1